Peter Abrahamson, Faicd

Peter Abrahamson, Faicd Email and Phone Number

Peter Abrahamson, Faicd's Location
Greater Sydney Area, Australia
Peter Abrahamson, Faicd's Contact Details

Peter Abrahamson, Faicd work email

Peter Abrahamson, Faicd personal email

n/a
About Peter Abrahamson, Faicd

COMPANY DIRECTOR ♦ SENIOR BUSINESS EXECUTIVE ♦ BUSINESS ADVISORCEO and Board Member with over twenty years of board level experience across the publicly listed and private for-profit sectors from large multinationals to small start-ups. With over 30 years’ experience in the pharmaceutical, medical device and FMCG sectors both in Australia and across Asia able to demonstrate a genuine passion for the health sector. As the MD of a biotech start-up (IP that will revolutionise the treatment of a common eye disease) developed and implementing the company’s strategy in preparation for out-licensing. Currently also represents the medical device industry on Government Committees making decisions on which technologies to list for reimbursement. Previously held a variety of senior roles for a US based publicly listed pharma and medical device group. Enhanced the competitive position of the organisation facing regulatory and competitive challenges. University degree qualified in Science and Business and accredited as Fellow of the Australian Institute of Company Directors._SPECIALTIES♦ Developing and implementing commercial and corporate strategy♦ Managing multinational subsidiaries with P&L, sales, marketing, finance & regulatory responsibilities♦ Identifying and leading business re-structuring and change initiatives♦ Negotiating in and out-licensing deals.

Peter Abrahamson, Faicd's Current Company Details
Medical Technology Association of Australia (MTAA)

Medical Technology Association Of Australia (Mtaa)

View
Managing Director
Peter Abrahamson, Faicd Work Experience Details
  • Eyeco Pty Ltd
    Managing Director
    Eyeco Pty Ltd May 2015 - Present
    Sydney, Australia
    Eye Co was established in 2007 to identify and initiate the development of innovative proven and cost effective therapies for the treatment of retinal diseases such as Age Related Macular Degeneration and Diabetic Retinopathy. http://www.eyeco.com.au/.A business strategy has been established and implemented to identify, value and promote the company's IP among potential licensees and acquirers.
  • Medical Technology Association Of Australia (Mtaa)
    Independent Chair : Industry Code Committees
    Medical Technology Association Of Australia (Mtaa) Feb 2024 - Present
    Sydney, New South Wales, Australia
    Independent Chair of the Code Authority Committee and the Code Monitoring Committee
  • Macular Disease Foundation Australia
    Non Executive Director
    Macular Disease Foundation Australia Oct 2021 - Present
    Sydney, New South Wales, Australia
  • Aforethought Advisory
    Director & Founder
    Aforethought Advisory Oct 2012 - Jun 2022
    Sydney, Australia
    Provide strategic and tactical advice to the owners owners and senior executives of small and mid-sized enterprises across diverse industries on setting the direction of their businesses and provide ongoing implementation support.The firm implements corporate transformational and growth strategies with remuneration based on performance, or a fee for service or equity basis. SELECTED CONTRIBUTIONSIn a climate of internal conflict, guided the senior executive group of a consumer services business through a significant restructure to agree on the company’s direction and to formulate its strategic plan.Have been an advocate for the Medical Technology Association of Australia to represent the medical devices industry on a committee comprising the Department of Human Services & Health, medical specialists and private health insurers that makes decisions about whether new medical devices are to be listed for reimbursement. Have mentored senior executives at NRMA, BT, Westpac, News Limited and other organisations. _________________________________________________________________________________
  • Respia Technologies
    Chairman, Advisory Board
    Respia Technologies Oct 2020 - Feb 2022
    Sydney, New South Wales, Australia
    Respia is an asthma management system that tracks and records an asthmatic child’s respiratory health. The device, a patch applied to the childs chest, will be able to predict an imminent asthma attack and via a phone app warn the parent allowing timely application of medication thereby preventing an asthma attack and the associated consequences including hospitalisation.
  • Hd Medical Group
    Director
    Hd Medical Group Jan 2013 - Apr 2017
    Sydney, Australia
    Leading medical technology and products company that develops and commercialises breakthrough innovations in clinical diagnostics with a focus on high-end digital stethoscope technology.SELECTED CONTRIBUTIONSDeveloped and implemented a commercialisation strategy to elevate the profile of the company’s technology and capabilities amongst potential commercialisation, licensing and co-marketing partners globally.Have stimulated interest in licensing the technology in the US, Germany, Brazil, the UK, South Korea, Taiwan, Lebanon, and New Zealand and am negotiating terms and securing regulatory approvals.Identified sources of funding from the Australian Government, prepared and submitted R&D funding applications and lobbied decision makers on the significance of the company’s technology.Providing commercial and market based input into the design of the company’s next generation of technologies. _________________________________________________________________________________
  • Caroline Chisolm Lodge Pty Ltd & Caroline Chisolm Manor Pty Ltd
    Director
    Caroline Chisolm Lodge Pty Ltd & Caroline Chisolm Manor Pty Ltd 2015 - Nov 2016
  • Mergeco International
    Director
    Mergeco International Sep 2011 - Dec 2013
    Sydney, Australia
    Corporate advisory firm providing strategic and tactical advice to companies seeking significant growth through mergers, acquisitions and alliances.SELECTED CONTRIBUTIONSFor a consumer health and beauty products company, mentored the CEO, facilitated a clear strategic direction, helped reposition the company from an Australian to a global focus and provided guidance and support to identify and appoint manufacturing, distribution and marketing partners. Leveraged my network to identify a marketing and distribution partner in Australia and New Zealand which enabled the company to focus on more substantial offshore opportunities. Assisted several companies across a diverse range of industries to develop highly creative solutions to resolve business issues and capitalise on opportunities. _________________________________________________________________________________
  • Consegna Group Limited
    Non-Executive Director
    Consegna Group Limited Oct 2011 - Mar 2012
    Sydney, Australia
    Previously the Helicon Group, the Consegna Group is an ASX listed company that identifies, acquires and commercialises late stage therapeutic delivery technologies. The company targets high value markets and indications using an acquisition strategy driven by strategic value creation, patent protection and realisation criteria.SELECTED CONTRIBUTIONSIdentified new product opportunities, evaluated their market potential, analysed the risks to evaluate potential regulatory hurdles, competitive intensity, margin, pricing and distribution requirements to enable the Board to make informed decisions on in-licensing and acquisition opportunities. Developed the company’s Corporate Governance Guidelines and ensured their adoption. _________________________________________________________________________________
  • Helicon Group Limited
    Non-Executive Director
    Helicon Group Limited Apr 2010 - Oct 2011
    Sydney, Australia
    _________________________________________________________________________________
  • Helicon Group Limited
    Managing Director
    Helicon Group Limited Jul 2005 - Apr 2010
    Sydney & Shanghai
    ASX listed start-up established to capitalise on the strong growth in the health care markets in China and North Asia.SELECTED CONTRIBUTIONSManaged the company’s ASX IPO. Included identifying licensing partners with commercially viable technologies willing to license their products to a newly established company, elevating the firm’s credibility by aligning it with reputable distribution and regulatory partners in China and influencing investors to join the Board by in-licensing four significant technologies and aligning with reputable distribution and regulatory partners in target countries. Established the firm’s presence in Shanghai and built awareness, credibility and support for the new company among medical opinion leaders, regulatory authorities and distribution partners. Convinced Chinese regulatory authorities to register the company’s products for sale by engendering the support of regulatory consultants, local medical opinion leaders and patient groups. _________________________________________________________________________________
  • Amo Inc
    Vice President - Asia Pacific Region
    Amo Inc Feb 2002 - Jun 2003
    Hong Kong
    Global ophthalmic medical device development and marketing company.SELECTED CONTRIBUTIONSIn managing the spin-off of Allergan’s medical devices business in the Asia Pacific region to form AMO, established the company’s its offices, appointed distribution partners, implemented new organisational structures and formulated its business plans within three months to enable the business to trade successfully from inception. Retained key staff, aligned the sales and marketing teams to a new corporate culture and direction and ensured that sales and profit targets could be achieved. Avoided margin erosion through face to face distributor contract re-negotiations in nine Asian markets._________________________________________________________________________________
  • Allergan
    Managing Director - East Asia
    Allergan Jan 2000 - Feb 2002
    Hong Kong
    Leading global developer and marketer of eye care products and technologies.SELECTED CONTRIBUTIONSImproved the contribution margin from 15% of sales to 23% of sales. Re-structured the China business to become profitable and increased its contribution margin from 9% of sales to 22%.Increased the market share of lens care business in Greater China from 21% to 29%._________________________________________________________________________________
  • Allergan
    Managing Director - Australia & New Zealand
    Allergan Jan 1996 - Dec 1999
    Sydney, Australia
    SELECTED CONTRIBUTIONSDelivered an average sales growth rate of 9% and grew operating profits by an average of 14%.Sponsored the growth of the Scientific Affairs Group to enable participation in global Phase III clinical trials in Australia and New Zealand and improve the performance for time to regulatory and reimbursement approval.Generated significant demand for the company’s products by sponsoring the introduction of a training academy to educate consumers and in-store staff about product benefits._________________________________________________________________________________
  • Allergan
    Director Of Marketing
    Allergan Jul 1994 - Dec 1995
    Sydney, Australia
    __________________________________________________________________________________
  • Faulding Pharmaceuticals
    Business Development Manager / Sales & Marketing Manager
    Faulding Pharmaceuticals Jan 1990 - Jun 1994
    Adelaide, Australia
    _________________________________________________________________________________
  • Wellcome Australia
    Marketing Manager
    Wellcome Australia 1981 - 1989
    Sydney, Australia
    _________________________________________________________________________________
  • Unilever
    Product Manager
    Unilever Jan 1974 - Dec 1981
    Sydney, Australia

Peter Abrahamson, Faicd Skills

International Business Mergers Executive Management Start Ups Clinical Research Biotechnology Competitive Analysis Medical Devices Strategic Planning Management Consulting Business Planning Lifesciences New Business Development Change Management Project Planning Market Analysis Business Strategy Management Product Development Product Launch Pharmaceutical Industry Marketing Strategy Mergers And Acquisitions Commercialization

Peter Abrahamson, Faicd Education Details

Frequently Asked Questions about Peter Abrahamson, Faicd

What company does Peter Abrahamson, Faicd work for?

Peter Abrahamson, Faicd works for Medical Technology Association Of Australia (Mtaa)

What is Peter Abrahamson, Faicd's role at the current company?

Peter Abrahamson, Faicd's current role is Managing Director.

What is Peter Abrahamson, Faicd's email address?

Peter Abrahamson, Faicd's email address is ab****@****.com.au

What schools did Peter Abrahamson, Faicd attend?

Peter Abrahamson, Faicd attended Australian Intstitute Of Company Directors, Australian Graduate School Of Management, University Of New South Wales.

What skills is Peter Abrahamson, Faicd known for?

Peter Abrahamson, Faicd has skills like International Business, Mergers, Executive Management, Start Ups, Clinical Research, Biotechnology, Competitive Analysis, Medical Devices, Strategic Planning, Management Consulting, Business Planning, Lifesciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.